Opportunity ID: 329200
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH21-2122 |
Funding Opportunity Title: | Strengthen Capacity of South African Government’s Department of Health and Implementing Partners to Deliver Quality Differentiated, Advanced Clinical Care (ACC) for Unstable HIV and TB/HIV Patients in the Republic of South Africa (SA) under PEPFAR |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 5 |
Posted Date: | Jan 11, 2021 |
Last Updated Date: | Mar 24, 2021 |
Original Closing Date for Applications: | Mar 12, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Current Closing Date for Applications: | Apr 09, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | – |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $1,500,000 for Year 1, subject to the availability of funds.In SA, it is estimated that 20% of patients newly initiating anti-retroviral therapy (ART) present late and 10-15% of patients on first line ART are failing treatment, leading to poor retention, especially in the first 12 months of treatment. This NOFO seeks to decrease morbidity and mortality, improve treatment retention and viral load (VL) suppression of HIV and TB/HIV co-infected patients through the use of innovative capacity building approaches for health service providers to better manage complicated and unstable HIV and TB/HIV co-infected patients. Activities under this NOFO must include but are not limited to: building in-country capacity through in-person and other innovative capacity-building approaches in ACC to effectively manage complicated HIV and TB/HIV co-infected patients; building a cadre of local expertise through a Train the Trainer model; and using existing virtual platforms and technological tools to provide technical assistance (TA) to facility-based staff on management of complicated HIV and TB/HIV patients.Expected NOFO outcomes must include but are not limited to: increased competencies among health workers in providing appropriate services to manage complicated HIV and TB/HIV patients; improved quality of ACC services offered by the trained health care providers; and improved referral for genotypic testing services for eligible clients with VL failure. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
dln6@cdc.gov Email:dln6@cdc.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Due to an update in our application packages on Grants.gov, if you retrieved a package before today March 24, 2021, you will have to retrieve an updated application package with the new versions of the updated forms. If you have any questions please contact ogstims@cdc.gov. |
Mar 24, 2021 | |
Administrative Amendment | Jan 11, 2021 | |
Amended NOFO. | Jan 11, 2021 | |
Amendment | Jan 11, 2021 | |
Jan 11, 2021 | ||
Sep 24, 2020 | ||
Sep 24, 2020 |
DISPLAYING: Synopsis 5
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH21-2122 |
Funding Opportunity Title: | Strengthen Capacity of South African Government’s Department of Health and Implementing Partners to Deliver Quality Differentiated, Advanced Clinical Care (ACC) for Unstable HIV and TB/HIV Patients in the Republic of South Africa (SA) under PEPFAR |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 5 |
Posted Date: | Jan 11, 2021 |
Last Updated Date: | Mar 24, 2021 |
Original Closing Date for Applications: | Mar 12, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Current Closing Date for Applications: | Apr 09, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | – |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $1,500,000 for Year 1, subject to the availability of funds.In SA, it is estimated that 20% of patients newly initiating anti-retroviral therapy (ART) present late and 10-15% of patients on first line ART are failing treatment, leading to poor retention, especially in the first 12 months of treatment. This NOFO seeks to decrease morbidity and mortality, improve treatment retention and viral load (VL) suppression of HIV and TB/HIV co-infected patients through the use of innovative capacity building approaches for health service providers to better manage complicated and unstable HIV and TB/HIV co-infected patients. Activities under this NOFO must include but are not limited to: building in-country capacity through in-person and other innovative capacity-building approaches in ACC to effectively manage complicated HIV and TB/HIV co-infected patients; building a cadre of local expertise through a Train the Trainer model; and using existing virtual platforms and technological tools to provide technical assistance (TA) to facility-based staff on management of complicated HIV and TB/HIV patients.Expected NOFO outcomes must include but are not limited to: increased competencies among health workers in providing appropriate services to manage complicated HIV and TB/HIV patients; improved quality of ACC services offered by the trained health care providers; and improved referral for genotypic testing services for eligible clients with VL failure. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
dln6@cdc.gov Email:dln6@cdc.gov |
DISPLAYING: Synopsis 4
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH21-2122 |
Funding Opportunity Title: | Strengthen Capacity of South African Government’s Department of Health and Implementing Partners to Deliver Quality Differentiated, Advanced Clinical Care (ACC) for Unstable HIV and TB/HIV Patients in the Republic of South Africa (SA) under PEPFAR |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 4 |
Posted Date: | Jan 11, 2021 |
Last Updated Date: | Mar 22, 2021 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Apr 09, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | – |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $1,500,000 for Year 1, subject to the availability of funds.
In SA, it is estimated that 20% of patients newly initiating anti-retroviral therapy (ART) present late and 10-15% of patients on first line ART are failing treatment, leading to poor retention, especially in the first 12 months of treatment. This NOFO seeks to decrease morbidity and mortality, improve treatment retention and viral load (VL) suppression of HIV and TB/HIV co-infected patients through the use of innovative capacity building approaches for health service providers to better manage complicated and unstable HIV and TB/HIV co-infected patients. Activities under this NOFO must include but are not limited to: building in-country capacity through in-person and other innovative capacity-building approaches in ACC to effectively manage complicated HIV and TB/HIV co-infected patients; building a cadre of local expertise through a Train the Trainer model; and using existing virtual platforms and technological tools to provide technical assistance (TA) to facility-based staff on management of complicated HIV and TB/HIV patients. Expected NOFO outcomes must include but are not limited to: increased competencies among health workers in providing appropriate services to manage complicated HIV and TB/HIV patients; improved quality of ACC services offered by the trained health care providers; and improved referral for genotypic testing services for eligible clients with VL failure. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
dln6@cdc.gov Email:dln6@cdc.gov |
DISPLAYING: Synopsis 3
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH21-2122 |
Funding Opportunity Title: | Strengthen Capacity of South African Government’s Department of Health and Implementing Partners to Deliver Quality Differentiated, Advanced Clinical Care (ACC) for Unstable HIV and TB/HIV Patients in the Republic of South Africa (SA) under PEPFAR |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 3 |
Posted Date: | Jan 11, 2021 |
Last Updated Date: | Mar 04, 2021 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Apr 09, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | – |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $1,500,000 for Year 1, subject to the availability of funds.
In SA, it is estimated that 20% of patients newly initiating anti-retroviral therapy (ART) present late and 10-15% of patients on first line ART are failing treatment, leading to poor retention, especially in the first 12 months of treatment. This NOFO seeks to decrease morbidity and mortality, improve treatment retention and viral load (VL) suppression of HIV and TB/HIV co-infected patients through the use of innovative capacity building approaches for health service providers to better manage complicated and unstable HIV and TB/HIV co-infected patients. Activities under this NOFO must include but are not limited to: building in-country capacity through in-person and other innovative capacity-building approaches in ACC to effectively manage complicated HIV and TB/HIV co-infected patients; building a cadre of local expertise through a Train the Trainer model; and using existing virtual platforms and technological tools to provide technical assistance (TA) to facility-based staff on management of complicated HIV and TB/HIV patients. Expected NOFO outcomes must include but are not limited to: increased competencies among health workers in providing appropriate services to manage complicated HIV and TB/HIV patients; improved quality of ACC services offered by the trained health care providers; and improved referral for genotypic testing services for eligible clients with VL failure. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
dln6@cdc.gov Email:dln6@cdc.gov |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH21-2122 |
Funding Opportunity Title: | Strengthen Capacity of South African Government’s Department of Health and Implementing Partners to Deliver Quality Differentiated, Advanced Clinical Care (ACC) for Unstable HIV and TB/HIV Patients in the Republic of South Africa (SA) under PEPFAR |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Jan 11, 2021 |
Last Updated Date: | Mar 02, 2021 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Apr 05, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | – |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $1,500,000 for Year 1, subject to the availability of funds.
In SA, it is estimated that 20% of patients newly initiating anti-retroviral therapy (ART) present late and 10-15% of patients on first line ART are failing treatment, leading to poor retention, especially in the first 12 months of treatment. This NOFO seeks to decrease morbidity and mortality, improve treatment retention and viral load (VL) suppression of HIV and TB/HIV co-infected patients through the use of innovative capacity building approaches for health service providers to better manage complicated and unstable HIV and TB/HIV co-infected patients. Activities under this NOFO must include but are not limited to: building in-country capacity through in-person and other innovative capacity-building approaches in ACC to effectively manage complicated HIV and TB/HIV co-infected patients; building a cadre of local expertise through a Train the Trainer model; and using existing virtual platforms and technological tools to provide technical assistance (TA) to facility-based staff on management of complicated HIV and TB/HIV patients. Expected NOFO outcomes must include but are not limited to: increased competencies among health workers in providing appropriate services to manage complicated HIV and TB/HIV patients; improved quality of ACC services offered by the trained health care providers; and improved referral for genotypic testing services for eligible clients with VL failure. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
dln6@cdc.gov Email:dln6@cdc.gov |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH21-2122 |
Funding Opportunity Title: | Strengthen Capacity of South African Government’s Department of Health and Implementing Partners to Deliver Quality Differentiated, Advanced Clinical Care (ACC) for Unstable HIV and TB/HIV Patients in the Republic of South Africa (SA) under PEPFAR |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 3 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jan 11, 2021 |
Last Updated Date: | Jan 11, 2021 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Mar 12, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | – |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $10,000,000 for Year 1, subject to the availability of funds.
In SA, it is estimated that 20% of patients newly initiating anti-retroviral therapy (ART) present late and 10-15% of patients on first line ART are failing treatment, leading to poor retention, especially in the first 12 months of treatment. This NOFO seeks to decrease morbidity and mortality, improve treatment retention and viral load (VL) suppression of HIV and TB/HIV co-infected patients through the use of innovative capacity building approaches for health service providers to better manage complicated and unstable HIV and TB/HIV co-infected patients. Activities under this NOFO must include but are not limited to: building in-country capacity through in-person and other innovative capacity-building approaches in ACC to effectively manage complicated HIV and TB/HIV co-infected patients; Expected NOFO outcomes must include but are not limited to: increased competencies among health workers in providing appropriate services to manage complicated HIV and TB/HIV patients; |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
dln6@cdc.gov Email:dln6@cdc.gov |
DISPLAYING: Forecast 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH21-2122 |
Funding Opportunity Title: | Strengthen Capacity of South African Government’s Department of Health and Implementing Partners to Deliver Quality Differentiated, Advanced Clinical Care (ACC) for Unstable HIV and TB/HIV Patients in the Republic of South Africa (SA) under PEPFAR |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 3 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Forecast 2 |
Posted Date: | Sep 24, 2020 |
Last Updated Date: | Jan 11, 2021 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | – |
Archive Date: | – |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $10,000,000 for Year 1, subject to the availability of funds.In SA, it is estimated that 20% of patients newly initiating anti-retroviral therapy (ART) present late and 10-15% of patients on first line ART are failing treatment, leading to poor retention, especially in the first 12 months of treatment. This NOFO seeks to decrease morbidity and mortality, improve treatment retention and viral load (VL) suppression of HIV and TB/HIV co-infected patients through the use of innovative capacity building approaches for health service providers to better manage complicated and unstable HIV and TB/HIV co-infected patients. Activities under this NOFO must include but are not limited to:•building in-country capacity through in-person and other innovative capacity-building approaches in ACC to effectively manage complicated HIV and TB/HIV co-infected patients;•building a cadre of local expertise through a Train the Trainer model; and•using innovative virtual platforms and technological tools to provide technical assistance (TA) to facility-based staff on management of complicated HIV and TB/HIV patients.Expected NOFO outcomes must include but are not limited to:•increased competencies among health workers in providing appropriate services to manage complicated HIV and TB/HIV patients; and•improved quality of ACC services offered by the trained health care providers; and improved referral for genotypic testing services for eligible clients with VL failure. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:dln6@cdc.gov |
DISPLAYING: Forecast 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-GH21-2122 |
Funding Opportunity Title: | Strengthen Capacity of South African (SA) Government’s Department of Health and Implementing Partners to Deliver Quality Differentiated, Advanced Clinical Care (ACC) for Unstable HIV and TB/HIV Patients in the Republic of SA under PEPFAR |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 3 |
Assistance Listings: | 93.067 — Global AIDS |
Cost Sharing or Matching Requirement: | No |
Version: | Forecast 1 |
Posted Date: | Sep 24, 2020 |
Last Updated Date: | Sep 24, 2020 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | – |
Archive Date: | – |
Estimated Total Program Funding: | $0 |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: |
Additional Information
Agency Name: | Centers for Disease Control – CGH |
Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $10,000,000 for Year 1, subject to the availability of funds. In SA, it is estimated that 20% of patients newly initiating anti-retroviral therapy (ART) present late and 10-15% of patients on first line ART are failing treatment, leading to poor retention, especially in the first 12 months of treatment. This NOFO seeks to decrease morbidity and mortality, improve treatment retention and viral load (VL) suppression of HIV and TB/HIV co-infected patients through the use of innovative capacity building approaches for health service providers to better manage complicated and unstable HIV and TB/HIV co-infected patients. Activities under this NOFO must include but are not limited to:•building in-country capacity through in-person and other innovative capacity-building approaches in ACC to effectively manage complicated HIV and TB/HIV co-infected patients;•building a cadre of local expertise through a Train the Trainer model; and•using innovative virtual platforms and technological tools to provide technical assistance (TA) to facility-based staff on management of complicated HIV and TB/HIV patients. Expected NOFO outcomes must include but are not limited to:•increased competencies among health workers in providing appropriate services to manage complicated HIV and TB/HIV patients; and•improved quality of ACC services offered by the trained health care providers; and improved referral for genotypic testing services for eligible clients with VL failure. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:dln6@cdc.gov |
Related Documents
Packages
Agency Contact Information: | Emily Dale dln6@cdc.gov Email: dln6@cdc.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.067 | CDC-RFA-GH21-2122 | Strengthen Capacity of South African Government’s Department of Health and Implementing Partners to Deliver Quality Differentiated, Advanced Clinical Care (ACC) for Unstable HIV and TB/HIV Patients in the Republic of South Africa (SA) under PEPFAR | PKG00264914 | Dec 10, 2020 | Apr 09, 2021 | View |